Germline fitness-based scoring of cancer mutations

Genetics

Volumn 188, Issue 2, 2011, Pages 383-393

  Fischer, Andrej ^a,b   Greenman, Chris ^a   Mustonen, Ville ^a  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CYSTEINE; GLYCINE; PROTEIN; THREONINE; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CALIBRATION; CANCER GENETICS; CONTROLLED STUDY; GENE DELETION; GENE DOSAGE; GENE LOCUS; GENE TARGETING; GENETIC VARIABILITY; GERM LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; MISSENSE MUTATION; NEOPLASM; ONCOGENE; PRIORITY JOURNAL; PROTEIN DOMAIN; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE;

ALGORITHMS; AMINO ACID SEQUENCE; BASE SEQUENCE; GENETIC FITNESS; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GERM-LINE MUTATION; HUMANS; MODELS, GENETIC; MUTATION, MISSENSE; NEOPLASMS; ONCOGENES; POLYMORPHISM, GENETIC; SELECTION, GENETIC; SEQUENCE HOMOLOGY, AMINO ACID; TUMOR SUPPRESSOR PROTEINS;

EID: 79958221522     PISSN: 00166731     EISSN: 00166731     Source Type: Journal    
DOI: 10.1534/genetics.111.127480     Document Type: Article

References (61)

1. Beerenwinkel, N., T. Antal, D. Dingli, A. Traulsen, K.W. Kinzler et al., 2007 Genetic progression and the waiting time to cancer. PLoS Comput. Biol. 3: e225.
2. Berg, J., S. Willmann and M. Lässig, 2004 Adaptive evolution of transcription factor binding sites. BMC Evol. Biol. 4: 1.
3. Bignell, G. R., C. D. Greenman, H. Davies, A. P. Butler and S. Edkins et al., 2010 Signatures of mutation and selection in the cancer genome. Nature 463: 893-898.
4. Bozic, I., T. Antal, H. Ohtsuki, H. Carter, D. Kim et al., 2010 Accumulation of driver and passenger mutations during tumor progression. Proc. Natl. Acad. Sci. USA 107: 18545-18550.
5. Bromberg, Y., and B. Rost, 2007 SNAP: predict effect of nonsynonymous polymorphisms on function. Nucleic Acids Res. 35: 3823-3835.
6. Bulmer, M., 1991 The selection-mutation-drift theory of synonymous codon usage. Genetics 129: 897-907.
7. Carter, H., S. Chen, L. Isik, S. Tyekucheva, V. E. Velculescu et al., 2009 Cancer-specific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations. Cancer Res. 69: 6660-6667.
8. Clifford, R. J., M. N. Edmonson, C. Nguyen and K. H. Buetow, 2004 Large-scale analysis of non-synonymous coding region single nucleotide polymorphisms. Bioinformatics 20: 1006-1014.
9. Davies, H., G. R. Bignell, C. Cox, P. Stephens, S. Edkins et al., 2002 Mutations of the BRAF gene in human cancer. Nature 417: 949-954.
10. Ding, L., G. Getz, D. A. Wheeler, E. R. Mardis, M. D. McLellan et al., 2008 Somatic mutations affect key pathways in lung adenocarcinoma. Nature 455: 1069-1075.
11. Dixit, A., L. Yi, R. Gowthaman, A. Torkamani, N. J. Schork et al., 2009 Sequence and structure signatures of cancer mutation hotspots in protein kinases. PLoS ONE 4: e7485.
12. Doniger, S. W., and J. C. Fay, 2007 Frequent gain and loss of functional transcription factor binding sites. PLoS Comput. Biol. 3: e99.
13. Durbin, R., S. Eddy, A. Krogh and G. Mitchison, 1998 Biological Sequence Analysis: Probabilistic Models of Proteins and Nucleic Acids. Cambridge University Press, Cambridge, UK/London/ New York.
14. Eyre-Walker, A., 2006 The genomic rate of adaptive evolution. Trends Ecol. Evol. (Amst.) 21: 569-575.
15. Fay, J. C., and C. I. Wu, 2000 Hitchhiking under positive Darwinian selection. Genetics 155: 1405-1413.
16. Finn, R. D., J. Mistry, J. Tate, P. Coggill, A. Heger et al., 2010 The Pfam protein families database. Nucleic Acids Res. 38(Database issue): D211-D222.
17. Frank, S. A., 2010 Evolution in health and medicine Sackler colloquium: somatic evolutionary genomics: mutations during development cause highly variable genetic mosaicism with risk of cancer and neurodegeneration. Proc. Natl. Acad. Sci. USA 107 (Suppl 1): 1725-1730.
18. Gardiner, C. W., 2009 Stochastic Methods: A Handbook for the Natural and Social Sciences. Springer, Heidelberg.
19. Greenman, C., R. Wooster, P. A. Futreal, M. R. Stratton and D. F. Easton, 2006 Statistical analysis of pathogenicity of somatic mutations in cancer. Genetics 173: 2187-2198.
20. Greenman, C., P. Stephens, R. Smith, G. L. Dalgliesh, C. Hunter et al., 2007 Patterns of somatic mutation in human cancer genomes. Nature 446: 153-158.
21. Halpern, A. L., and W. J. Bruno, 1998 Evolutionary distances for protein-coding sequences: modeling site-specific residue frequencies. Mol. Biol. Evol. 15: 910-917.
22. Henikoff, J. G., and S. Henikoff, 1996 Using substitution probabilities to improve position-specific scoring matrices. Bioinformatics 12: 135-143.
23. Hirschhorn, J. N., and M. J. Daly, 2005 Genome-wide association studies for common diseases and complex traits. Nat. Rev. Genet. 6: 95-108.
24. International Cancer Genome Consortium, 2010 International network of cancer genome projects. Nature 464: 993-998.
25. Izarzugaza, J. M. G., O. C. Redfern, C. A. Orengo and A. Valencia, 2009 Cancer-associated mutations are preferentially distributed in protein kinase functional sites. Proteins 77: 892-903.
26. Jordan, D. M., V. E. Ramensky and S. R. Sunyaev, 2010 Human allelic variation: perspective from protein function, structure, and evolution. Curr. Opin. Struct. Biol. 20: 342-350.
27. Kaminker, J. S., Y. Zhang, C. Watanabe and Z. Zhang, 2007 Can-Predict: a computational tool for predicting cancer-associated missense mutations. Nucleic Acids Res. 35(Web Server issue): W595-W598.
28. Kan, Z., B. S. Jaiswal, J. Stinson, V. Janakiraman, D. Bhatt et al., 2010 Diverse somatic mutation patterns and pathway alterations in human cancers. Nature 466: 869-873.
29. Kimura, M., 1955 Stochastic processes and distribution of gene frequencies under natural selection. Cold Spring Harbor Symp. Quant. Biol. 20: 33-53.
30. Kimura, M., 1964 Diffusion models in population genetics. J. Appl. Probab. 1: 177-232.
31. Kreitman, M., 2000 Methods to detect selection in populations with applications to the human. Annu. Rev. Genomics Hum. Genet. 1: 539-559.
32. Kryukov, G. V., L. A. Pennacchio and S. R. Sunyaev, 2007 Most rare missense alleles are deleterious in humans: implications for complex disease and association studies. Am. J. Hum. Genet. 80: 727-739.
33. Lahiry, P., A. Torkamani, N. J. Schork and R. A. Hegele, 2010 Kinase mutations in human disease: interpreting genotype-phenotype relationships. Nat. Rev. Genet. 11: 60-74.
34. Lawrence, C. E., S. F. Altschul, M. S. Boguski, J. S. Liu, A. F. Neuwald et al., 1993 Detecting subtle sequence signals: a Gibbs sampling strategy for multiple alignment. Science 262: 208-214.
35. Lee, W., P. Yue and Z. Zhang, 2009a Analytical methods for inferring functional effects of single base pair substitutions in human cancers. Hum. Genet. 126: 481-498.
36. Lee, W., Y. Zhang, K. Mukhyala, R. A. Lazarus and Z. Zhang, 2009b Bi-directional SIFT predicts a subset of activating mutations. PLoS ONE 4: e8311.
37. Li, L., K. Zhang, J. Lee, S. Cordes, D. P. Davis et al., 2009 Discovering cancer genes by integrating network and functional properties. BMC Med. Genomics 2: 61.
38. Manning, G., D. B. Whyte, R. Martinez, T. Hunter and S. Sudarsanam, 2002 The protein kinase complement of the human genome. Science 298: 1912-1934.
39. Merlo, L. M. F., J. W. Pepper, B. J. Reid and C. C. Maley, 2006 Cancer as an evolutionary and ecological process. Nat. Rev. Cancer 6: 924-935.
40. Mort, M., U. S. Evani, V. G. Krishnan, K. K. Kamati, P. H. Baenziger et al., 2010 In silico functional profiling of human disease-associated and polymorphic amino acid substitutions. Hum. Mutat. 31: 335-346.
41. Moses, A. M., and R. Durbin, 2009 Inferring selection on amino acid preference in protein domains. Mol. Biol. Evol. 26: 527-536.
42. Moses, A. M., D. Y. Chiang, D. A. Pollard, V. N. Iyer and M. B. Eisen, 2004 MONKEY: identifying conserved transcriptionfactor binding sites in multiple alignments using a binding sitespecific evolutionary model. Genome Biol. 5: R98.
43. Mustonen, V., and M. Lässig, 2005 Evolutionary population genetics of promoters: predicting binding sites and functional phylogenies. Proc. Natl. Acad. Sci. USA 102: 15936-15941.
44. Ng, P. C., and S. Henikoff, 2001 Predicting deleterious amino acid substitutions. Genome Res. 11: 863-874.
45. Ng, P. C., and S. Henikoff, 2003 SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res. 31: 3812-3814.
46. Nielsen, R., 2005 Molecular signatures of natural selection. Annu. Rev. Genet. 39: 197-218.
47. Pruitt, K. D., T. Tatusova and D. R. Maglott, 2007 NCBI reference sequences (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Res. 35(Database issue): D61-D65.
48. Radivojac, P., P. H. Baenziger, M. G. Kann, M. E. Mort, M. W. Hahn et al., 2008 Gain and loss of phosphorylation sites in human cancer. Bioinformatics 24: i241-i247.
49. Ramensky, V. E., P. Bork and S. R. Sunyaev, 2002 Human nonsynonymous SNPs: server and survey. Nucleic Acids Res. 30: 3894-3900.
50. Rouzine, I. M., A. Rodrigo and J. M. Coffin, 2001 Transition between stochastic evolution and deterministic evolution in the presence of selection: general theory and application to virology. Microbiol. Mol. Biol. Rev. 65: 151-185.
51. Rubin, A. F., and P. Green, 2009 Mutation patterns in cancer genomes. Proc. Natl. Acad. Sci. USA 106: 21766-21770.
52. Sawyer, S. A., and D. L. Hartl, 1992 Population genetics of polymorphism and divergence. Genetics 132: 1161-1176.
53. Sjöblom, T., S. Jones, L. D. Wood, D. W. Parsons, J. Lin et al., 2006 The consensus coding sequences of human breast and colorectal cancers. Science 314: 268-274.
54. Stratton, M. R., P. J. Campbell and A. Futreal, 2009 The cancer genome. Nature 458: 719-724.
55. Talavera, D., M. S. Taylor and J. M. Thornton, 2010 The (non) malignancy of cancerous amino acidic substitutions. Proteins 78: 518-529.
56. Torkamani, A., and N. J. Schork, 2008 Prediction of cancer driver mutations in protein kinases. Cancer Res. 68: 1675-1682.
57. Torkamani, A., N. Kannan, S. Taylor and N. Schork, 2008 Congenital disease SNPs target lineage specific structural elements in protein kinases. Proc. Natl. Acad. Sci. USA 105: 9011-9016.
58. Torkamani, A., G. Verkhivker and N. J. Schork, 2009 Cancer driver mutations in protein kinase genes. Cancer Lett. 281: 117-127.
59. Whitmarsh, A., and R. Davis, 2007 Role of mitogen-activated protein kinase kinase 4 in cancer. Oncogene 26: 3172-3184.
60. Yang, Z., S. Ro and B. Rannala, 2003 Likelihood models of somatic mutation and codon substitution in cancer genes. Genetics 165: 695-705.
61. Yue, P., W. F. Forrest, J. S. Kaminker, S. Lohr, Z. Zhang et al., 2010 Inferring the functional effects of mutation through clusters of mutations in homologous proteins. Hum. Mutat. 31: 264-271.